Article
Prognostic DNA Methylation Biomarkers in Ovarian Cancer
1 May 2006
Abstract excerpt
PURPOSE: Aberrant DNA methylation, now recognized as a contributing factor to neoplasia, often shows definitive gene/sequence preferences unique to specific cancer types. Correspondingly, distinct combinations of methylated loci can function as biomarkers for numerous clinical correlates of ovarian and other cancers. EXPERIMENTAL DESIGN: We used a microarray approach to identify methylated loci prognostic for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
